🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Urologic Diseases

Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin NCT06886464Phase 22 sites📍 Calgary📍 Edmonton Matthew James · Tests: Cilastatin Sodium, Placebo-Saline Nephrotic Syndrome Study Network NCT01209000n/a44 sites📍 Los Angeles📍 Palo Alto📍 San Francisco University of Michigan · Tests: Kidney Biopsy Hospital at Home for Elderly Acute Ill Patients NCT05360914NA3 sites📍 Silkeborg📍 Skive📍 Viborg Defactum, Central Denmark Region · Tests: Hospital at Home (HaH) treatment, Standard hospital admission Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors NCT04916132n/a13 sites📍 Skejby📍 Copenhagen📍 Hillerød Herlev Hospital · Tests: Kidney Biopsy Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease NCT06497387EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: PRG-1801 Protecting Kidneys Through a Low Protein Diet: A Stepwise Multiple-Choice System Approach NCT03979534NA2 sites📍 La Flèche📍 Le Mans Centre Hospitalier le Mans · Tests: low protein diet A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis NCT07499700Phase 2, Phase 31 site📍 Beijing Bio-Thera Solutions · Tests: BAT4406F, Placebos Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System NCT07247136NA1 site📍 West Columbia Neuspera Medical, Inc. · Tests: Neuspera Implantable Sacral Neuromodulation System Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer NCT03379909Phase 23 sites📍 Nijmegen📍 Rotterdam📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Metformin Intravenous Versus Oral Treatment of the Main Acute Infections NCT06715306NA7 sites📍 Aabenraa📍 Copenhagen📍 Copenhagen University of Southern Denmark · Tests: Oral treatment Antibiotic Prophylaxis for Ureteroscopy With a Negative Pressure Suction Sheath NCT07246967NA1 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: not use any prophylactic antimicrobials, use prophylactic antimicrobials Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes NCT05498116Phase 41 site📍 Aurora University of Colorado, Denver · Tests: Montelukast, Placebo A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites📍 Duarte📍 La Jolla📍 Ann Arbor Incyte Corporation · Tests: INCA036873 A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) NCT06721143Phase 1, Phase 22 sites📍 Miami📍 Miami AION Healthspan, Inc. · Tests: AION-301, Placebo WIRE - Novel Treatments in Renal Cell Cancer NCT03741426Phase 27 sites📍 Cambridge📍 Edinburgh📍 Exeter CCTU- Cancer Theme · Tests: Olaparib, Cediranib, Volrustomig, Rilvegostomig Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria NCT03301038Phase 21 site📍 Philadelphia Children's Hospital of Philadelphia · Tests: Rifampin Cerebrovascular Disease: Quality of Life (CODE: QoL) NCT06443268n/a1 site📍 Zurich University of Zurich · Tests: questionnaire, hair samples, blood samples, clinical exam Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell NCT07062549Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: 111In-XYIMSR-01 WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients NCT07447791NA1 site📍 London Guy's and St Thomas' NHS Foundation Trust · Tests: low intensity of CRRT, usual intensity of CRRT Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers NCT03413982n/a1 site📍 Kansas City University of Kansas Medical Center · Tests: Registry Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer NCT04823923NA5 sites📍 Marseille📍 Montpellier📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: blood sampling for ITK dosage Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment NCT06679920NA2 sites📍 Amsterdam📍 Amsterdam Amsterdam UMC · Tests: Optical coherence tomography Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study NCT07508124Phase 43 sites📍 Houston📍 Katy📍 Seattle Baylor College of Medicine · Tests: betamethasone valerate 0.1% cream, Placebo cream Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS) NCT06721260n/a2 sites📍 Kansas City📍 Kansas City University of Kansas Medical Center Quality and Outcome Measurements of Urological Patients NCT04763538n/a2 sites📍 Biel📍 Biel Insel Gruppe AG, University Hospital Bern · Tests: Standard of care Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC) NCT07359235Phase 11 site📍 Wuhan Tongji Hospital · Tests: KD01(the recombinant oncolytic adenovirus) Early PKD Observational Cohort Study NCT02936791n/a3 sites📍 Chicago📍 Kansas City📍 Kansas City University of Kansas Medical Center A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib Protocollo N 2014 - Benign Prostatic Hyperplasia NCT06182189n/a1 site📍 Milan IRCCS San Raffaele · Tests: Observation of patients with a benign prostatic hyperplasia condition
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy